1. Home
  2. BC vs EWTX Comparison

BC vs EWTX Comparison

Compare BC & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brunswick Corporation

BC

Brunswick Corporation

N/A

Current Price

$76.09

Market Cap

4.0B

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

N/A

Current Price

$46.41

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BC
EWTX
Founded
1845
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.3B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
BC
EWTX
Price
$76.09
$46.41
Analyst Decision
Buy
Strong Buy
Analyst Count
19
13
Target Price
★ $88.06
$55.42
AVG Volume (30 Days)
824.4K
★ 1.6M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 2.30%
N/A
EPS Growth
N/A
★ N/A
EPS
2.93
★ 8.86
Revenue
★ $5,362,800,000.00
N/A
Revenue This Year
$7.41
N/A
Revenue Next Year
$5.56
N/A
P/E Ratio
$26.09
★ $5.19
Revenue Growth
★ 2.40
N/A
52 Week Low
$59.06
$19.76
52 Week High
$90.25
$48.78

Technical Indicators

Market Signals
Indicator
BC
EWTX
Relative Strength Index (RSI) 56.98 62.79
Support Level $74.64 $37.22
Resistance Level $76.28 $47.36
Average True Range (ATR) 2.98 3.14
MACD 0.18 0.94
Stochastic Oscillator 62.00 80.22

Price Performance

Historical Comparison
BC
EWTX

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns more than 450 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: